doxifluridine has been researched along with Carcinoma, Hepatocellular in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Lin, X; Liu, X; Ma, Y; Wu, M; Xue, F | 1 |
| Li, RP; Liang, P; Tang, H | 1 |
| Fan, J; Liu, YK; Shen, ZZ; Tang, ZY; Wu, ZQ; Xiao, YS; Xue, Q; Ye, SL; Zhao, Y; Zhou, J | 1 |
| Wang, HD; Zheng, JF | 1 |
| Jin, H; Kano, M; Kinugasa, A; Nishigami, T; Sawada, K; Shimoyama, T; Shintani, S; Wada, M; Yamamura, M; Yamashita, M | 1 |
| Fukagawa, H; Hirohashi, Y; Iwanaga, A; Iyama, A; Kitahara, K; Miyazaki, K; Mori, M; Sasatomi, E; Tsutsumi, N; Yakushiji, H | 1 |
| Mizuno, M; Ogino, M; Tanaka, Y; Tokuda, H; Yamauchi, M | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Koida, I; Kumada, H; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A | 1 |
| Allegrini, G; Bartolozzi, C; Brunetti, I; Conte, PF; Di Marsico, R; Falcone, A; Fontana, E; Lencioni, M; Masi, G; Orlandini, C; Pfanner, E; Stampino, CG | 1 |
| Chiang, TT; Lai, KH; Lay, CS; Lee, SD; Ng, WW; Tsai, YT; Wang, JY; Wang, SS; Yang, CF; Yeh, YS | 1 |
3 trial(s) available for doxifluridine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
A prospective randomized administration of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Combined Modality Therapy; Embolization, Therapeutic; Female; Floxuridine; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Survival Rate; Treatment Outcome | 1997 |
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study.
Topics: Administration, Oral; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Disease-Free Survival; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Male; Middle Aged; Survival Analysis | 2000 |
Clinical trial of doxifluridine in the treatment of primary hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Clinical Trials as Topic; Female; Floxuridine; Humans; Liver Neoplasms; Male; Middle Aged; Taiwan | 1986 |
7 other study(ies) available for doxifluridine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Doxifluridine-based pharmacosomes delivering miR-122 as tumor microenvironments-activated nanoplatforms for synergistic treatment of hepatocellular carcinoma.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Floxuridine; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; Liver Neoplasms; MicroRNAs; Tumor Microenvironment | 2021 |
[Establishment of a 5-DFUR-resistant human hepatocellular carcinoma cell model and preliminary study of the mechanisms of the drug resistance].
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Floxuridine; Glutathione Transferase; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2008 |
Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.
Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Cell Movement; Disease-Free Survival; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Complementary; Floxuridine; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Liver Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Thymidine Phosphorylase; Transfection | 2005 |
5-Fluorouracil concentration in blood, liver and tumor tissues and apoptosis of tumor cells after preoperative oral 5'-deoxy-5-fluorouridine in patients with hepatocellular carcinoma.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Female; Floxuridine; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Preoperative Care | 2005 |
Simultaneous occurrence of adenomas in stomach, duodenal bulb, and colon: disappearance of gastric and duodenal adenomas during oral administration of 5'-deoxy-5-fluorouridine.
Topics: Adenoma; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Colonic Neoplasms; Duodenal Neoplasms; Floxuridine; Humans; Isomerism; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Stomach Neoplasms | 1994 |
[A comparative study on the serum and tissue 5-FU concentrations in patients with hepatocellular carcinoma after preoperative oral administration of UFT and 5'-DFUR].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1994 |
[A case of hepatocellular carcinoma responding to oral administration of 5'-DFUR].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Floxuridine; Humans; Liver Cirrhosis; Liver Neoplasms; Remission Induction | 1996 |